Please Wait.....
Report
Canada Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 68 Pages I Mordor Intelligence
Canada Cardiovascular Devices Market Analysis
The Canada cardiovascular devices market size reached USD 1.7 billion in 2025 and is expected to climb to USD 2.30 billion by 2030, translating into a 6.22% CAGR across 2025-2030. Growing procedure volumes tied to an aging population, provincial capital spending on cardiac catheterization labs, and the rapid expansion of remote patient monitoring platforms are setting a durable growth foundation for the Canada cardiovascular devices market. Solid gains are occurring even as centralized group purchasing organizations (GPOs) negotiate lower unit prices, forcing manufacturers to prove quantifiable clinical and economic value. Provincial commitments such as Ontario's USD 31 million Windsor cath-lab expansion and Alberta's fast-tracked Red Deer opening are intensifying competition among suppliers vying for procurement lots. Meanwhile, the Medical Device Single Audit Program (MDSAP) is compressing regulatory timelines, although Health Canada approvals for next-generation ablation catheters continue to lag FDA clearances by several months.
Canada Cardiovascular Devices Market Trends and Insights
Aging Population Driving Procedure Volumes
Nineteen percent of Canadians are now 65 or older, a proportion projected to rise steadily through 2030. Seniors account for 27% of diagnosed ischemic heart disease cases, creating sustained demand for advanced stents, valve implants, and monitoring devices. Beyond sheer volume, older patients present higher comorbidity loads, steering hospitals toward minimally invasive approaches that lower perioperative risk. Device makers are therefore prioritizing smaller-profile catheters and AI-assisted imaging that simplify complex anatomies and shorten recovery times. Provincial health ministries increasingly link capital budgets to population-aging metrics, reinforcing the long-term pull on the Canada cardiovascular devices market.
Provincial Funding for New Catheterization & EP Labs
Ontario's USD 31 million Windsor Regional Hospital project will add a second cath table and enable 24-hour service, addressing local wait lists and lifting utilization of coronary guide wires, drug-eluting stents, and hemostasis devices. Alberta's decision to open Red Deer's lab five years early has similar ripple effects, boosting demand for radiopaque contrast, radial access kits, and mapping catheters in the region. Quebec's St. Mary's General Hospital, funded for a third lab, now manages 43% higher patient throughput than comparable facilities, amplifying purchases of ablation consoles and structural heart closure systems. Collectively, these targeted outlays are reshaping procurement schedules and intensifying supplier competition in the Canada cardiovascular devices market.
Provincial GPOs Compress Premium-Device Pricing
Value-oriented tenders from organizations such as HealthPRO and Mohawk MedBuy are generating 8-12% price reductions on premium cardiovascular products. Suppliers must now furnish longitudinal cost-effectiveness data and real-world outcome evidence to secure formulary positions, raising pre-sale investment requirements. Tiered rebate structures tied to readmission metrics are also gaining traction, incentivizing manufacturers to support post-implant remote monitoring and training programs.
Other drivers and restraints analyzed in the detailed report include:
Rapid Uptake of Minimally Invasive Transcatheter Therapies / Elevated Diabetes & Obesity Rates among Indigenous Populations / Health Canada Licence Lag for Next-Gen Ablation Catheters /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Diagnostic and monitoring devices, however, are on course for a 6.98% CAGR, signaling rising preference for preventive and home-based care. Hospitals continue to allocate sizable capital toward transcatheter valves, drug-eluting stents, and mapping catheters, but provincial telehealth funding now channels incremental dollars toward wearable ECG sensors and cloud-connected blood-pressure systems. Hamilton Health Sciences' MyChart Care Companion program illustrates this pivot, enrolling heart-failure patients in continuous symptom tracking that reduced readmissions during 2024 pilots.
Real-world evidence reinforces the economic advantage of early detection. Boston Scientific's mCRM System delivered a 97.5% complication-free rate in Canadian trial sites, bolstering hospital case for adopting leadless pacemaker-S-ICD combinations. Parallel advances in AI interpretation lower clinician workload and accelerate diagnoses, expanding addressable volumes for monitoring devices nationwide. The Canada cardiovascular devices market readily absorbs these innovations, supported by MDSAP-enabled synchronized North American launches.
The Canada Cardiovascular Devices Market Report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic and Surgical), Application (Coronary Artery Disease, Arrhythmia & Conduction Disorders, and More), End User (Hospitals & Cardiac Centres, Ambulatory Surgical Centres, and More). The Market Forecasts are Provided in Terms of Value (USD), Based On Availability.
List of Companies Covered in this Report:
Medtronic / Abbott Laboratories / Boston Scientific / Edwards Lifesciences Corp. / Johnson & Johnson (Biosense Webster / Cordis) / Terumo Corp. / GE Healthcare Technologies / Siemens Healthineers / Koninklijke Philips / Stryker / LivaNova / BIOTRONIK / MicroPort / Merit Medical Systems / Cook Group / Cardinal Health / Zimmer Biomet / Opsens Inc. / AngioDynamics / LeMaitre Vascular / Getinge /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Aging Population Driving Procedure Volumes Across Provinces
4.2.2 Provincial Funding for New Catheterization & EP Labs (Ontario & Quebec)
4.2.3 Rapid Uptake of Minimally-Invasive Transcatheter Therapies to Cut Surgical Wait-Times
4.2.4 Elevated Diabetes & Obesity Rates among Indigenous/Northern Canadians Accelerating CAD Onset
4.2.5 MDSAP Harmonization Streamlining Device Approvals for Multinationals
4.2.6 Med-tech Clusters in Toronto & Vancouver Fueling Domestic Wearable/Cardiac-AI Innovation
4.3 Market Restraints
4.3.1 Provincial Group Purchasing Organizations (GPOs) Compress Premium-Device Pricing
4.3.2 Health Canada Licence Lag vs. FDA for Next-Gen Ablation Catheters
4.3.3 Rural Dispersion Limiting Access to Advanced Cardiology Centres
4.3.4 Reimbursement Push-back After High-Profile Implant Longevity Recalls
4.4 Value / Supply-Chain Analysis
4.5 Regulatory Landscape
4.6 Technology Outlook
4.7 Porter's Five Forces
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Suppliers
4.7.3 Bargaining Power of Buyers
4.7.4 Threat of Substitutes
4.7.5 Competitive Rivalry
5 Market Size & Growth Forecasts
5.1 By Product Type
5.1.1 Diagnostic & Monitoring Devices
5.1.1.1 ECG Systems
5.1.1.2 Remote Cardiac Monitor
5.1.1.3 Cardiac MRI
5.1.1.4 Cardiac CT
5.1.1.5 Echocardiography / Ultrasound
5.1.1.6 Fractional Flow Reserve (FFR) Systems
5.1.2 Therapeutic & Surgical Devices
5.1.2.1 Coronary Stents
5.1.2.1.1 Drug-Eluting Stents
5.1.2.1.2 Bare-Metal Stents
5.1.2.1.3 Bioresorbable Stents
5.1.2.2 Catheters
5.1.2.2.1 PTCA Balloon Catheters
5.1.2.2.2 IVUS/OCT Catheters
5.1.2.3 Cardiac Rhythm Management
5.1.2.3.1 Pacemakers
5.1.2.3.2 Implantable Cardioverter Defibrillators
5.1.2.3.3 Cardiac Resynchronization Therapy Devices
5.1.2.4 Heart Valves
5.1.2.4.1 TAVR/TAVI
5.1.2.4.2 Mechanical Valves
5.1.2.4.3 Tissue/Bioprosthetic Valves
5.1.2.5 Ventricular Assist Devices
5.1.2.6 Artificial Hearts
5.1.2.7 Grafts & Patches
5.1.2.8 Other Cardiovascular Surgical Devices
5.2 By Application
5.2.1 Coronary Artery Disease
5.2.2 Arrhythmia & Conduction Disorders
5.2.3 Heart Failure & Cardiomyopathy
5.2.4 Structural & Congenital Heart Defects
5.2.5 Peripheral Vascular Disease
5.3 By End User
5.3.1 Hospitals & Cardiac Centres
5.3.2 Ambulatory Surgical Centres
5.3.3 Cardiology/EP Clinics
5.3.4 Home-care & Remote Monitoring Programs
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 Medtronic plc
6.3.2 Abbott Laboratories
6.3.3 Boston Scientific Corp.
6.3.4 Edwards Lifesciences Corp.
6.3.5 Johnson & Johnson (Biosense Webster / Cordis)
6.3.6 Terumo Corp.
6.3.7 GE Healthcare Technologies
6.3.8 Siemens Healthineers AG
6.3.9 Philips Healthcare
6.3.10 Stryker Corp.
6.3.11 LivaNova PLC
6.3.12 Biotronik SE & Co. KG
6.3.13 MicroPort Scientific
6.3.14 Merit Medical Systems
6.3.15 Cook Medical
6.3.16 Cardinal Health Inc.
6.3.17 Zimmer Biomet Holdings Inc.
6.3.18 Opsens Inc.
6.3.19 AngioDynamics Inc.
6.3.20 LeMaitre Vascular
6.3.21 Getinge
7 Market Opportunities & Future Outlook
7.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security